Review article · 2025 · Open access

Oral–Gut Microbiota Crosstalk and Epigenetic Targets in Metabolic and Neuropsychiatric Diseases

Sahar Mostafavi, Shabnam Nohesara, Ahmad Pirani, Hamid M. Abdolmaleky, Sam Thiagalingam

Nutrients, 17(21), 3367 · Published 27 October 2025 · DOI 10.3390/nu17213367

Open PDFView at the publisherCite this paper

In brief

“Oral–Gut Microbiota Crosstalk and Epigenetic Targets in Metabolic and Neuropsychiatric Diseases” is a 2025 review article by Sahar Mostafavi and 4 co-authors, published in Nutrients. OpenAlex counts 5 citations as of 18 November 2026, which puts it in the top 3% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Nutrients.

Citations
5
Most cited in
2026 (5)
Field-weighted impact
0.35
References
153
Authors
5

Abstract

The oral cavity contains a diverse group of bacteria in the saliva, as well as structured aggregates of bacterial cells on the mucosal surfaces. Oral microbiota (OM) dysbiosis not only induces local inflammation, it can also trigger systemic inflammation leading to metabolic diseases and neuropsychiatric diseases (NPDs). While primary evidence indicates that oral microbiota dysbiosis induces gut microbiota aberrations, which exacerbate inflammation associated with metabolic diseases (obesity, dyslipidemia, diabetes, nonalcoholic fatty liver disease (NAFLD), and insulin resistance), other studies revealed the contribution of the oral microbiota-brain axis in the pathogenesis of NPDs. GM dysbiosis and inflammation also induce epigenetic alterations in cytokine genes, such as IL-1β, IL-6, TNF-α, NF-kB, BTLA, IL-18R1, TGF-β, P13k/Akt1, Ctnnb1, and Hsp90aa1, as well as DNMTs, HDACs, and DAT1 associated with the development and progression of metabolic disorders and/or NPDs. Therefore, the epigenome could serve as a target for preventive or therapeutic interventions. Here, we (i) review emerging evidence of the potential impact of OM dysbiosis in the pathogenesis of metabolic diseases and NPDs, (ii) highlight the relationship between OM-induced inflammation and epigenetic alterations driving NPDs pathogenesis and interlinked metabolic aberrations, (iii) discuss therapeutic approaches capable of treating metabolic diseases and NPDs through reshaping the microbiota and its epigenetic metabolites, and hence mitigating epigenetic aberrations linked to metabolic diseases and NPDs. Finally, we outline challenges and current research gaps related to investigating the relationship between microbiota, epigenetic aberrations, and metabolic abnormalities associated with NPDs.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Mostafavi, S., Nohesara, S., Pirani, A., Abdolmaleky, H. M., & Thiagalingam, S. (2025). Oral–Gut Microbiota Crosstalk and Epigenetic Targets in Metabolic and Neuropsychiatric Diseases. Nutrients, 17(21), 3367. https://doi.org/10.3390/nu17213367

MLA 9

Mostafavi, Sahar, et al. “Oral–Gut Microbiota Crosstalk and Epigenetic Targets in Metabolic and Neuropsychiatric Diseases.” Nutrients, vol. 17, no. 21, 2025, p. 3367. https://doi.org/10.3390/nu17213367.

Chicago

Mostafavi, Sahar, Shabnam Nohesara, Ahmad Pirani, Hamid M. Abdolmaleky, and Sam Thiagalingam. 2025. “Oral–Gut Microbiota Crosstalk and Epigenetic Targets in Metabolic and Neuropsychiatric Diseases.” Nutrients 17 (21): 3367. https://doi.org/10.3390/nu17213367.

Harvard

Mostafavi, S. et al. (2025) ‘Oral–Gut Microbiota Crosstalk and Epigenetic Targets in Metabolic and Neuropsychiatric Diseases’, Nutrients, 17(21), p. 3367. doi:10.3390/nu17213367.

IEEE

S. Mostafavi, S. Nohesara, A. Pirani, H. M. Abdolmaleky, and S. Thiagalingam, “Oral–Gut Microbiota Crosstalk and Epigenetic Targets in Metabolic and Neuropsychiatric Diseases,” Nutrients, vol. 17, no. 21, p. 3367, 2025, doi: 10.3390/nu17213367.

BibTeX

@article{mostafavi2025oral,
  title     = {{Oral–Gut Microbiota Crosstalk and Epigenetic Targets in Metabolic and Neuropsychiatric Diseases}},
  author    = {Mostafavi, Sahar and Nohesara, Shabnam and Pirani, Ahmad and Abdolmaleky, Hamid M. and Thiagalingam, Sam},
  journal   = {Nutrients},
  year      = {2025},
  volume    = {17},
  number    = {21},
  pages     = {3367},
  doi       = {10.3390/nu17213367},
  url       = {https://doi.org/10.3390/nu17213367}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health

  • oral microbiota
  • gut microbiota
  • oral-gut axis
  • dysbiosis
  • epigenetic modifications
  • metabolic disorders
  • neuropsychiatric disorders
  • systemic inflammation

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Mostafavi, S., Nohesara, S., Pirani, A., Abdolmaleky, H. M., & Thiagalingam, S. (2025). Oral–Gut Microbiota Crosstalk and Epigenetic Targets in Metabolic and Neuropsychiatric Diseases. Nutrients, 17(21), 3367. https://doi.org/10.3390/nu17213367

How many times has this paper been cited?

5 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Nutrients: sign in and open the PDF from this page.

Who wrote this paper?

Sahar Mostafavi, Shabnam Nohesara, Ahmad Pirani, Hamid M. Abdolmaleky, Sam Thiagalingam.

What is the DOI of this paper?

10.3390/nu17213367, permanently at https://doi.org/10.3390/nu17213367. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.